{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-207417","form_type":"8-K","ticker":"OSCR","cik":"0001568651","company_name":"Oscar Health, Inc.","filed_at":"2025-09-18T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.383936+00:00","generated_at":"2026-05-17T06:14:54.332967+00:00","sec_items":["1.01","2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Oscar Health issues $410M of 2.25% convertible notes due 2030; net proceeds ~$395.8M","bullets":["Notes carry 2.25% coupon, mature Sep 1, 2030; initial conversion price ~$24.82 per share.","Net proceeds of ~$395.8M used $34.4M for capped calls; balance for AI, care cost reduction, growth.","Initial purchasers fully exercised $55M option; capped calls cap price $37.46 per share.","Notes subordinated to senior debt; structurally subordinated to subsidiary liabilities."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-207417","json":"https://secwatch.observer/filing/0001193125-25-207417.json","markdown":"https://secwatch.observer/filing/0001193125-25-207417.md","text":"https://secwatch.observer/filing/0001193125-25-207417.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1568651/000119312525207417/0001193125-25-207417-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1568651/000119312525207417/d74904d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T06:14:54.332967+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"98318e05b465932988671fb7540e6f1e2a907406","claim":"Oscar Health, Inc. issued a maximum of 21,889,982 shares of the Company's class A common stock may be issued upon conversion of the Notes of convertible note to initial purchasers for $410,000,000 aggregate principal amount of 2.25% Convertible Senior Subordinated Notes due 2030, net proceeds approximately $395.8 million.","evidence_excerpt":"accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 1.01. Entry Into a Material Definitive Agreement. Indenture and Notes On September 18, 2025, Oscar Health, Inc. (the “ Company ”) issued $410,000,000 aggregate principal amount of its 2.25% Convertible Senior Subordinated Notes due 2030 (the “ Notes ”). The Notes were","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1568651/000119312525207417/0001193125-25-207417-index.htm","confidence":0.95,"family_label":"Equity Issuances","details":[{"label":"Security","value":"convertible note"},{"label":"Shares","value":"a maximum of 21,889,982 shares of the Company's class A common stock may be issued upon conversion of the Notes"},{"label":"Purchaser","value":"initial purchasers"},{"label":"Consideration","value":"$410,000,000 aggregate principal amount of 2.25% Convertible Senior Subordinated Notes due 2030, net proceeds approximately $395.8 million"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}